NeoGenomics Inc (NEO)
15.38
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Market Cap: 1.975B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.972B |
| November 19, 2024 | 1.972B |
| November 18, 2024 | 1.927B |
| November 15, 2024 | 1.931B |
| November 14, 2024 | 2.027B |
| November 13, 2024 | 2.109B |
| November 12, 2024 | 2.096B |
| November 11, 2024 | 2.099B |
| November 08, 2024 | 2.024B |
| November 07, 2024 | 2.031B |
| November 06, 2024 | 1.984B |
| November 05, 2024 | 1.916B |
| November 04, 2024 | 1.815B |
| November 01, 2024 | 1.797B |
| October 31, 2024 | 1.740B |
| October 30, 2024 | 1.728B |
| October 29, 2024 | 1.731B |
| October 28, 2024 | 1.726B |
| October 25, 2024 | 1.674B |
| October 24, 2024 | 1.671B |
| October 23, 2024 | 1.674B |
| October 22, 2024 | 1.693B |
| October 21, 2024 | 1.681B |
| October 18, 2024 | 1.737B |
| October 17, 2024 | 1.729B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.771B |
| October 15, 2024 | 1.797B |
| October 14, 2024 | 1.769B |
| October 11, 2024 | 1.733B |
| October 10, 2024 | 1.734B |
| October 09, 2024 | 1.665B |
| October 08, 2024 | 1.721B |
| October 07, 2024 | 1.765B |
| October 04, 2024 | 1.785B |
| October 03, 2024 | 1.808B |
| October 02, 2024 | 1.836B |
| October 01, 2024 | 1.769B |
| September 30, 2024 | 1.889B |
| September 27, 2024 | 1.858B |
| September 26, 2024 | 1.876B |
| September 25, 2024 | 1.917B |
| September 24, 2024 | 2.025B |
| September 23, 2024 | 2.025B |
| September 20, 2024 | 2.086B |
| September 19, 2024 | 2.112B |
| September 18, 2024 | 2.071B |
| September 17, 2024 | 2.088B |
| September 16, 2024 | 2.093B |
| September 13, 2024 | 2.102B |
| September 12, 2024 | 2.076B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
816.32M
Minimum
Oct 21 2022
6.992B
Maximum
Feb 12 2021
2.964B
Average
2.261B
Median
Market Cap Benchmarks
| Bruker Corp | 8.525B |
| Henry Schein Inc | 9.198B |
| Karyopharm Therapeutics Inc | 96.48M |
| Apellis Pharmaceuticals Inc | 3.449B |
| Beam Therapeutics Inc | 1.953B |
Market Cap Related Metrics
| PS Ratio | 3.018 |
| Price to Book Value | 2.174 |
| Price | 15.38 |
| Earnings Yield | -3.96% |